Phase I study of IMM2510, a PD-L1/ VEGF bispecific antibody, in participants with advanced IO-treated SQ-NSCLC. This is an ASCO Meeting Abstract from the 2026 ASCO Annual Meeting I. This abstract does ...
Astrum Financial (8333) has delivered a 120.340% change over the past year, with a 52-week range between 0.280 and 0.720. What Is the Average Daily Trading Volume of Astrum Financial (8333)? The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results